SCHEMBL2324932

SCHEMBL2324932

COC(=O)[C@H](CCS(=O)(=O)O)NC(=O)c1ccccc1-c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLPP Q16740 2/20 0.48
TACR3 P29371 4/20 0.46
FNTA P49354 3/20 0.45
FNTB P49356 3/20 0.45
TDP1 Q9NUW8 1/20 0.45
GAA P10253 2/20 0.44
POLB P06746 1/20 0.44
CHRNB2 P17787 2/20 0.43
CHRNB4 P30926 2/20 0.43
CHRNA3 P32297 2/20 0.43
CHRNA4 P43681 2/20 0.43
TACR2 P21452 3/20 0.42
KMT2A Q03164 3/20 0.42
TSHR P16473 2/20 0.42
KDM4E B2RXH2 2/20 0.42
MEN1 O00255 2/20 0.42
PGGT1B P53609 1/20 0.42
ALDH1A1 P00352 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2326177 0.91 CLPP (0.47) CLPPGAAPOLBCHRNB2CHRNB4
SCHEMBL2329544 0.90 CLPP (0.46) CLPPGAAPOLBCHRNB2CHRNB4
SCHEMBL2324236 0.88 TACR3 (0.47) CLPPTACR3FNTAFNTBTDP1
SCHEMBL2331418 0.88 CLPP (0.44) CLPPTACR3TDP1GAAPOLB
SCHEMBL2333528 0.87 CHRNB2 (0.47) CLPPGAACHRNB2CHRNB4CHRNA3
SCHEMBL2327761 0.84 HPGD (0.50) KMT2ATSHRALDH1A1TAS1R3TAS1R1
SCHEMBL2328548 0.83 CA1 (0.51) TDP1GAAKMT2AALDH1A1HSD17B10
SCHEMBL22679207 0.82 MEN1 (0.54) CLPPTACR3FNTAFNTBTDP1
SCHEMBL17571368 0.82 MEN1 (0.54) CLPPTACR3FNTAFNTBTDP1
SCHEMBL2329474 0.81 FNTA (0.63) FNTAFNTBTDP1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2356979-B1 ANTI-WRINKLE AGENTS POLA CHEM IND INC (JP) 2017-10-25 EP disclosed
EP-3173063-A1 ANTI-WRINKLE AGENTS Pola Chemical Industries Inc. (JP) 2017-05-31 EP disclosed
US-8835498-B2 Anti-wrinkle agents POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-16 US disclosed
US-20110245343-A1 ANTI-WRINKLE AGENTS POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed
EP-2356979-A1 ANTI-WRINKLE AGENTS Pola Chemical Industries Inc. (JP) 2011-08-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245343-A1 ANTI-WRINKLE AGENTS GLA, H1-4, H1-3 CLPP 4826/4885TACR3 4307/4885FNTA 4644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.